Anti-CA19-9/Sialyl Lewisa Antibody BHA10207102

Mfr.No.	MSM1-25-P0
Alternative Names	CA19.9 ; Ovarian tumor antigen ; Pancreatic tumor antigen ; Sialyl Lewis a
Antigen	CA19-9/Sialyl Lewisa
Categories	Primary Antibodies
Cellular Localization	Cytoplasmic
Clonality	Monoclonal
Conjugate	Unconjugated
Description	CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
Host	Mouse
Immunogen	Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Positive Control	Stomach or Colon Carcinoma
Reactivity	Human
Recombinant	FALSE
Regulatory	RUO

Swissprot	Not Known (Human)
Uniprot	Not Known (Human)
Gene Id	Not Known (Human)

Buffer	200μg/ml of Ab purified from Bioreactor Concentrate. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA at 1.0mg/ml.
Concentration	200µg/ml
Description	There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity	Purified Ab with BSA and Azide at 200μg/ml

Applications

FACS, IF, IHC-F

Description

(Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined., FACS ; IF ; IHC-F

Dilution

FACS	0.5-1μg/million cells
IF	0.5-1μg/ml
IHC-F	0.5-1.0μg/ml for 30 minutes at RT

Download

Have you used this product?

Rate it now..!!

SKU	Supplier No.	Size	Your price	Quantity
BHA10207102	MSM1-25-P0	20µg	$204.67		Add to Cart
BHA10207102	MSM1-25-P0	100µg	$393.20		Add to Cart

Anti-CA19-9/Sialyl Lewisa Antibody BHA10207102

Contact us to order

Tel

Email

Contact us to order

Tel

Email

Reviews of Anti-CA19-9/Sialyl Lewisa Antibody BHA10207102

Rate it now..!!